Total Payments
$628,973
2024 Payments
$58,055
Companies
80
Transactions
2,275
Payment Breakdown by Category
Other$467,100 (74.3%)
Consulting$60,377 (9.6%)
Food & Beverage$50,681 (8.1%)
Travel$42,787 (6.8%)
Research$7,826 (1.2%)
Education$202.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $461,913 | 238 | 73.4% |
| Consulting Fee | $60,377 | 33 | 9.6% |
| Food and Beverage | $50,681 | 1,895 | 8.1% |
| Travel and Lodging | $42,787 | 82 | 6.8% |
| Unspecified | $7,826 | 6 | 1.2% |
| Honoraria | $5,100 | 2 | 0.8% |
| Education | $202.50 | 17 | 0.0% |
| Grant | $87.90 | 2 | 0.0% |
Payments by Type
General
$621,147
2,269 transactions
Research
$7,826
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $138,582 | 288 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $121,222 | 158 | $0 (2024) |
| Lilly USA, LLC | $81,655 | 151 | $0 (2024) |
| Amgen Inc. | $48,323 | 70 | $0 (2018) |
| IMPEL PHARMACEUTICALS INC. | $43,406 | 97 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $27,927 | 54 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $26,494 | 53 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $22,073 | 72 | $0 (2024) |
| Allergan, Inc. | $19,307 | 92 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $18,220 | 40 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,055 | 260 | ABBVIE INC. ($53,277) |
| 2023 | $48,780 | 258 | IMPEL PHARMACEUTICALS INC. ($21,047) |
| 2022 | $130,281 | 388 | ABBVIE INC. ($48,146) |
| 2021 | $65,984 | 300 | Lilly USA, LLC ($17,371) |
| 2020 | $74,701 | 291 | Lilly USA, LLC ($37,547) |
| 2019 | $69,660 | 235 | Teva Pharmaceuticals USA, Inc. ($40,923) |
| 2018 | $97,104 | 279 | Amgen Inc. ($40,908) |
| 2017 | $84,409 | 264 | Ipsen Biopharmaceuticals, Inc ($19,578) |
All Payment Transactions
2,275 individual payment records from CMS Open Payments — Page 1 of 91
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/24/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: PAIN | ||||||
| 12/23/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Neurology | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: PAIN | ||||||
| 12/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.09 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.22 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: EPILEPSY | ||||||
| 11/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neurology | ||||||
| 11/26/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.15 | General |
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.65 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Neurology | ||||||
| 11/20/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $0.41 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | Eli Lilly and Company | $5,160 | 2 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN PATIENTS 6 TO 17 YEARS OF AGE WITH EPISODIC MIGRAINE - THE REBUILD STUDY | Eli Lilly and Company | $2,666 | 4 |
About Dr. Frank Berenson, MD
Dr. Frank Berenson, MD is a Neurology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689740987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Berenson, MD has received a total of $628,973 in payments from pharmaceutical and medical device companies, with $58,055 received in 2024. These payments were reported across 2,275 transactions from 80 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($461,913).
Ad
Practice Information
- Specialty Neurology
- Location Atlanta, GA
- Active Since 11/28/2006
- Last Updated 04/21/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1689740987
Products in Payments
- QULIPTA (Drug) $80,951
- UBRELVY (Drug) $71,043
- AJOVY (Drug) $69,011
- NURTEC ODT (Drug) $46,956
- AJOVY (Biological) $44,428
- EMGALITY (Drug) $43,783
- Trudhesa (Drug) $43,406
- REYVOW (Drug) $26,225
- ONZETRA Xsail (Drug) $24,697
- Dysport 300 U-1 (Drug) $19,566
- Aimovig (Biological) $18,800
- Cambia (Drug) $13,893
- Zembrace (Drug) $8,409
- TREXIMET (Drug) $8,132
- TROKENDI XR (Drug) $7,948
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $6,184
- BOTOX (Biological) $4,131
- ZEMBRACE SYMTOUCH (Drug) $3,673
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $2,830
- Briviact (Drug) $1,718
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlanta
Dr. Joash Lazarus, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Robert Gilbert, M.d, M.D
Neurology — Payments: $946,678
Neurology $946,678
Douglas Stuart, M.d, M.D
Neurology — Payments: $807,499
Neurology $807,499
Julio Flamini, M.d, M.D
Neurology — Payments: $554,096
Neurology $554,096
Lawrence Seiden, M.d, M.D
Neurology — Payments: $318,322
Neurology $318,322
Andrei Serbanescu, M.d, M.D
Neurology — Payments: $317,980
Neurology $317,980